RxDoctor Payments Data

Nicole Scribner

Nurse Practitioner · Albuquerque, NMNPI 1083481014

Payments from drug & device makers

$624in general payments, 2019–2025

Across 33 payments — averaging $18.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$143
  • Vifor Pharma, Inc.$89
  • Travere Therapeutics, Inc.$73
  • Fresenius USA Marketing, Inc.$64
  • Aurinia Pharma U.S., Inc.$50
  • Mallinckrodt Hospital Products Inc.$33
  • plus $174 from 8 others

What the payments were for

  • Food & beverage$624100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$624 in reported general payments places this provider in the 80th percentile of 624 nurse practitioner providers in New Mexico.

See all nurse practitioner providers in New Mexico

Medicare billing

Part B allowed, 2024
$27,668
Medicare patients
121
Services billed
284

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol45$28,029
Lanthanum Carbonate16$16,147
TrulicityDulaglutide13$12,559
JardianceEmpagliflozin19$12,240
MounjaroTirzepatide11$11,527
Sevelamer Carbonate11$2,416
Amlodipine Besylate46$562
Losartan Potassium52$517
Hydralazine Hcl26$309
Furosemide25$287
Lisinopril27$188
Hydrochlorothiazide12$30

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$32$28,02945 claims
Boehringer IngelheimJardiance$32$12,24019 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 624 nurse practitioner providers in New Mexico.

Other nurse practitioner in Albuquerque

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →